Ipamorelin Structure: Testing a Peptide With Three Unusual Residues
Most short research peptides are built entirely from the twenty standard amino acids, which makes their identity checks fairly routine. Ipamorelin is different. Of its five positions, only two hold ordinary L-amino acids, and each of the other three affects how the molecule should be tested. For QC staff handling ipamorelin in Canada, especially across a multi-vial order, knowing what each unusual residue does to the analysis is the difference between a thorough release check and one that quietly skips a question.
The sequence at a glance
Ipamorelin is written Aib-His-D-2-Nal-D-Phe-Lys-NH2. Its molecular formula is C38H49N9O5, its average molecular mass is about 711.9 g/mol, and its CAS number is 170851-70-4. Histidine at position 2 and lysine at position 5 are the only standard L residues.
| Position | Residue | What is unusual | Consequence for testing |
|---|---|---|---|
| 1 | Aib | Two methyl groups on the alpha carbon; no stereocentre | No D/L question here, but its peptide bond resists acid hydrolysis |
| 2 | L-His | Standard | None beyond routine |
| 3 | D-2-Nal | Naphthalene side chain, D configuration | Adds UV absorbance near 280 nm; configuration invisible to mass |
| 4 | D-Phe | Mirror-image form of phenylalanine | Same mass as L-Phe, so an inversion here passes a mass check |
| 5 | L-Lys amide | C-terminal amide rather than free acid | Free-acid variant differs by under 1 Da |
Aib at position 1
Alpha-aminoisobutyric acid can be pictured as alanine with its alpha hydrogen replaced by a second methyl. With two identical groups on the alpha carbon, the residue has no handedness at all, so it cannot racemise and has no D or L form to confirm. The extra methyl also restricts the backbone angles available at that position and makes the neighbouring bond a poor target for many proteases, which is why designers use it at the N-terminal end of several modified peptides.
There is one analytical catch. Peptide bonds next to Aib are known to be slow to break under standard acid hydrolysis. If a lab runs amino acid analysis on ipamorelin, incomplete cleavage at that bond can lower the apparent recovery of the residues involved, so hydrolysis time and conditions should be checked before low values are blamed on the material.
The naphthyl chromophore as a second identity signal
D-3-(2-naphthyl)alanine carries a fused two-ring aromatic system in place of phenylalanine’s single ring. It is considerably more hydrophobic and absorbs meaningfully in the region around 270 to 290 nm. Ipamorelin has no tryptophan or tyrosine, so without 2-Nal it would be almost invisible above the low-wavelength peptide-bond region.
That gives the analyst a useful extra check. Recording a second trace near 280 nm alongside the usual 214 nm channel, or a full diode-array spectrum across the main peak, provides identity evidence that is independent of mass. Impurities that have lost or altered the naphthyl group will show a different ratio between the two wavelengths than the main peak does.
What an ipamorelin mass result does and does not prove
The expected monoisotopic mass of the neutral molecule is close to 711.4, which appears in positive-mode electrospray as the protonated ion near m/z 712.4. A match confirms the elemental composition. Because Aib, 2-Nal and the amide terminus each have residue masses that differ from any standard amino acid, a correct mass effectively rules out an ordinary residue having been coupled in their place.
Mass spectrometry cannot see configuration. A molecule with L-Phe at position 4, or L-2-Nal at position 3, has exactly the same formula and the same mass as the correct compound. The mass result answers the composition question and leaves the stereochemistry question open.
Checking the two D-residues
Standard amino acid analysis does not close that gap. It breaks the peptide into free amino acids and measures them by side chain, which confirms that the right residues are present in the right proportions but does not separate D from L forms.
Two approaches address configuration directly:
- Chiral amino acid analysis. After hydrolysis, the free amino acids are tagged with a chiral reagent, Marfey’s reagent being a common choice, so that D and L forms of each residue separate chromatographically. Because acid hydrolysis itself causes a small amount of racemisation, careful methods correct for that background, for example by hydrolysing in deuterated acid.
- Diastereomer-resolving HPLC. Inverting one stereocentre in a peptide that has several creates a diastereomer rather than an enantiomer, and diastereomers can often be separated on an ordinary reversed-phase column. A method shown to resolve a reference epimer from ipamorelin can detect that impurity in the intact material.
Neither is routine at the research-supply level. Where one has been done, the certificate is answering a question most do not.
The C-terminal amide
Lysine 5 ends in a carboxamide. The corresponding free acid, which can arise from incomplete amidation or from the choice of resin, is about 0.98 Da heavier. On a molecule of roughly 712 Da that gap is easy for a high-resolution instrument to see, but on a low-resolution one it falls inside the isotope pattern. The terminal form should be stated on any certificate rather than left implied by the name.
A release checklist for ipamorelin in Canada
For labs receiving several vials or several sizes at once, a short, fixed routine keeps results comparable from order to order:
- Confirm the certificate states the full sequence, including D-configurations and the amide.
- Check the reported mass against about 711.9 g/mol average, or m/z 712.4 for the protonated ion.
- Look for a second UV trace near 280 nm, or add one to your own method.
- Note whether configuration was tested; if it was not, record that as an open item rather than a pass.
- Pair each group of vials with its certificate by cap and crimp colour and log lot, vial count and storage location.
Our ipamorelin is third-party tested for purity by HPLC, and certificates are published for some products on the certificates of analysis page. For the receptor side of the literature, see our article on ipamorelin’s selectivity at GHSR-1a.
Ipamorelin is supplied by Bulk Peptides for in-vitro laboratory research only and is not for use in humans or animals.
